Barinthus Biotherapeutics (BRNS) Tax Rate (2021 - 2026)

Barinthus Biotherapeutics has reported Tax Rate for 6 years, with the latest figure at 0.29% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 18.0% year-over-year to 0.29%; the trailing twelve-month figure through Mar 2026 stood at 0.32% (up 28.0% YoY), and the FY2025 full-year result was 0.26%, up 19.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.29%, down from 0.51% in the prior quarter.
• The five-year high for Tax Rate was 8.71% in Q4 2022, with the low at 50.44% in Q1 2022.
• Historically, Tax Rate has averaged 2.3% across 5 years, with a median of 0.24% in 2024.
• Annual changes were most pronounced in 2022 — Tax Rate plunged 5118 bps — and 2023, when it surged 5319 bps.
• Barinthus Biotherapeutics' Tax Rate stood at 8.71% in 2022, then tumbled by 48 bps to 4.53% in 2023, then sank by 100 bps to 0.01% in 2024, then surged by 3605 bps to 0.51% in 2025, then slumped by 44 bps to 0.29% in 2026.
• The last three Tax Rate figures came in at 0.29% (Q1 2026), 0.51% (Q4 2025), and 0.48% (Q3 2025), per Business Quant data.